The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection
Abstract
OBJECTIVE: Several recent studies have indicated that patients with adrenal incidentaloma often have disturbed glucose tolerance or/and hypertension. It is unclear whether these metabolic conditions could be caused by adrenal incidentaloma. We investigated the prevalence of disturbed glucose tolerance, hypertension and insulin resistance in the patients with non-functioning adrenal incidentaloma and evaluated the changes of the parameters such as glucose tolerance, blood pressure and insulin sensitivity after adrenalectomy. PATIENTS AND METHODS: Among 15 patients with incidentally discovered adrenal tumours in our department from 1996 to 1999, 4 patients were diagnosed as having pre-clinical Cushing's syndrome and the other 11 as having non-functioning tumours based on detailed endocrinological examinations including dexamethasone suppression testing. Four tumours with pre-clinical Cushing's syndrome and 8 tumours out of 11 patients with non-functioning tumours were diagnosed histopathologically as adrenocortical adenomas and the other 3 as of non-adrenal origin including a myelolipoma, an adrenal vascular cyst and an endothelioma. The prevalence of disturbed glucose tolerance was determined with an oral glucose tolerance test, and insulin sensitivity was evaluated by the method of steady state of plasma glucose (SSPG). RESULTS: All 12 patients with adrenocortical adenoma exhibited insulin resistance based on the SSPG (6.9-13.2 mmol/l). Before surgical removal of the tumours, the SSPG titre was relatively higher in the patients with pre-clinical Cushing's syndrome than in those with non-functioning with adrenocortical adenoma (mean value 11.65 vs. 8.99 mmol/l), whereas 2 of the 3 patients with non-adrenocortical tumours did not have insulin resistance. Among the 12 patients with adrenocortical adenoma, 7 (58%) and 9 (75%) patients exhibited hypertension and disturbed glucose tolerance, respectively. After removal of the tumours, SSPG of the patients with adrenocortical adenoma, but not that of the other 3 patients with non-cortical tumours, was significantly decreased compared to pre-adrenalectomy values. There are no significant differences in the changes of SSPG titres between in pre-clinical Cushing's syndrome and in non-functioning adrenocortical adenoma. Systolic blood pressure, but not diastolic blood pressure, was also significantly decreased in the patients with adrenocortical adenoma. CONCLUSION: High prevalences of disturbed glucose tolerance, insulin resistance and hypertension were found among the patients with non-functioning adrenocortical tumours. Adrenocortical adenoma may be one of the risk factors for insulin resistance that is believed to induce disturbed glucose tolerance and/or hypertension. Therefore, it is useful to evaluate insulin resistance for the patients with adrenal incidentalomas since results are likely to be helpful in deciding whether to remove the tumour by surgery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In more than 25% of AI subjects, the lack of cortisol suppression after 1-or 3-mg overnight DST or 2-d low-dose DST (LDDST) (19,34,41,44,46,48,53,55,56,60,61)”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [46]
In the citing paper
“Several studies (19,21,32,34,38,39,44,46,49,53,60,61,67) and recently the French Society for Endocrinology (68), however, have proposed a lower cutoff to increase sensitivity.”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [46]
In the citing paper
“some authors have proposed higher (3 or 8 mg) dexamethasone doses (40,46,54,56), which however did not show a better performance (14,23,66).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [46]
In the citing paper
“To date, the 1-mg DST is the most used test to diagnose SH, either alone (34 -36, 38, 44 -46) or in combination with other parameters (9, 18, 21, 32, 37, 39, 42, 49, 52-54, 56, 60, 61).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [46]
In the citing paper
“The determination of ACTH levels after CRH does not seem to add any advantage (1,23,34,35,37,38,46) to screening for SH.”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [46]
In the citing paper
“Several small studies suggested the improvement of blood pressure (54, 93, 95), glucose metabolism (46,54,93,95), and body weight (54,95) in surgically treated SH patients.”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [46]
In the citing paper
“Few studies evaluated the accuracy of the SH diagnosis before surgery to predict the improvement after surgery and, therefore, to address the treatment of choice in the individual subject (18,46,61,93).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [46]
In the citing paper
“This is of utmost importance because in several studies some of the surgically treated patients without SH experienced improvement of some metabolic endpoints (18,46,61,93).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [46]
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555
Recent Advances in Obesity Research
Bray, G. A. (1979) · Cited by 610
Reincke, M., Nieke, J., Krestin, G. P., Saeger, W., Allolio, B., & Winkelmann, W. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1517373 · Cited by 346
Angeli, A., Osella, G., Ali, A., & Terzolo, M. (1997) · Hormone Research · doi:10.1159/000185477 · Cited by 259
Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test
Pei, D., Jones, C. N. O., Bhargava, R., Chen, Y. I., & Reaven, G. M. (1994) · Diabetologia · doi:10.1007/bf00404344 · Cited by 209
Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)
Osella, G., Terzolo, M., Borretta, G., Magro, G., Alí, A., Piovesan, A., Paccotti, P., & Angeli, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989452 · Cited by 206
Leibowitz, G., Tsur, A., Chayen, S. D., Salameh, M., Raz, I., Cerasi, E., & Gross, D. J. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.737558.x · Cited by 180
Adrenocortical Tumors: Recent Advances in Basic Concepts and Clinical Management
Bornstein, S. R., Stratakis, C. A., & Chrousos, G. P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-9-199905040-00017 · Cited by 156
Adrenal incidentalomas: a manifestation of the metabolic syndrome?
Reincke, M., Faßnacht, M., Väth, S., Mora, P., & Allolio, B. (1996) · Endocrine Research · doi:10.1080/07435809609043773 · Cited by 133
Research works printed but not linked: 5
- Kuzuya T., 1997, Problem on the diagnostic criteria for diabetes mellitus, Japanese Journal of Clinical Medicine, 55, 247
- 10.1210/jc.79.6.1532 · DOI · Paper page
- 10.1210/jc.75.3.826 · DOI
- Tanaka K., 1997, CRH‐test, Japanese Journal of Clinical Medicine, 55, 341
- 10.1210/jc.81.2.740 · DOI
Cited by
Sorted by citations
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
AME Position Statement on adrenal incidentaloma
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., Reimondo, G., Pia, A., Toscano, V., Zini, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1147 · Cited by 523
Tauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.-A., Fazio, S., & Lombardi, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011766 · Cited by 400
Approach to the patient with an adrenal incidentaloma
Nieman, L. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0457 · Cited by 290
Occult Cushing’s syndrome in type-2 diabetes
Catargi, B., Rigalleau, V., Poussin, A., Ronci-Chaix, N., Bex, V., Vergnot, V., Gin, H., Roger, P., & Tabarin, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030254 · Cited by 287
Diagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279
Chiodini, I., Morelli, V., Salcuni, A. S., Eller-Vainicher, C., Torlontano, M., Coletti, F., Iorio, L., Cuttitta, A., Ambrosio, A., Vicentini, L., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2387 · Cited by 191
Subclinical Cushing’s syndrome in adrenal incidentalomas
Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G., & Angeli, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.008 · Cited by 179
Bancos, I., Alahdab, F., Crowley, R. K., Chortis, V., Delivanis, D. A., Erickson, D., Natt, N., Terzolo, M., Arlt, W., Young, W. F., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0465 · Cited by 167
Di Dalmazi, G., Berr, C. M., Fassnacht, M., Beuschlein, F., & Reincke, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1401 · Cited by 139
Subclinical Cushing’s syndrome: definition and management
Terzolo, M., Pia, A., & Reimondo, G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04253.x · Cited by 131
Exploration and management of adrenal incidentalomas.
Tabarin, A., Bardet, S., Bertherat, J. Y., Dupas, B., Chabre, O., Hamoir, E., Laurent, F., Tenenbaum, F., Cazalda, M., Lefèbvre, H., et al. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.09.003 · Cited by 129
Skeletal Muscle Insulin Resistance in Endocrine Disease
Peppa, Μ., Koliaki, C. C., Nikolopoulos, P., & Raptis, S. (2010) · BioMed Research International · doi:10.1155/2010/527850 · Cited by 129
Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study
Vassilatou, E., Vryonidou, A., Michalopoulou, S., Manolis, J., Caratzas, J., Phenekos, C., & Tzavara, I. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03492.x · Cited by 112
Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications.
Tsagarakis, S., Vassiliadi, D., & Thalassinos, N. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344133 · Cited by 113
Bernini, G., Moretti, A., Iacconi, P., Miccoli, P., Nami, R., Lucani, B., & Salvetti, A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480213 · Cited by 105
Iacobone, M., Citton, M., Viel, G., Boetto, R., Bonadio, I., Mondi, I., Tropea, S., Nitti, D., & Favia, G. (2012) · Surgery · doi:10.1016/j.surg.2012.08.054 · Cited by 101
Giordano, R., Marinazzo, E., Berardelli, R., Picu, A., Maccario, M., Ghigo, E., & Arvat, E. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0957 · Cited by 99
The prevalence of adrenal incidentaloma in routine clinical practice
Davenport, C., Liew, A., Doherty, B., Win, H. H. N., Misran, H., Hanna, S., Kealy, D., Al-Nooh, F., Agha, A., Thompson, C. J., et al. (2011) · Endocrine · doi:10.1007/s12020-011-9445-6 · Cited by 95
Ichijo, T., Ueshiba, H., Nawata, H., & Yanase, T. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0486 · Cited by 97
Yanase, T., Oki, Y., Katabami, T., Otsuki, M., Kageyama, K., Tanaka, T., Kawate, H., Tanabe, M., Doi, M., Akehi, Y., et al. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0456 · Cited by 90
Peppa, Μ., Boutati, E. I., Koliaki, C. C., Papaefstathiou, N., Garoflos, E., Economopoulos, T., Hadjidakis, D., & Raptis, S. (2010) · Metabolism · doi:10.1016/j.metabol.2010.01.007 · Cited by 89
Sereg, M., Szappanos, Á., Tőke, J., Karlinger, K., Feldman, K., Kaszper, É., Varga, I., Gláz, E., Rácz, K., & Tóth, M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0707 · Cited by 81
Surgery for Cushing’s Syndrome: An Historical Review and Recent Ten‐year Experience
Porterfield, J. R., Thompson, G. B., Young, W. F., Chow, J. T., Fryrear, R. S., II, van Heerden, J. A., Farley, D. R., Atkinson, J. L. D., Meyer, F. B., Abboud, C. F., et al. (2008) · World Journal of Surgery · doi:10.1007/s00268-007-9387-6 · Cited by 80
Subclinical Cushing's syndrome.
Terzolo, M., Reimondo, G., Bovio, S., & Angeli, A. (2004) · Pituitary · doi:10.1007/s11102-005-4024-6 · Cited by 80
Adrenal incidentaloma: a diagnostic challenge
Anagnostis, P. G., Karagiannis, A. I., Τζιόμαλος, Κ., Kakafika, A. I., Athyros, V. G., & Mikhailidis, D. P. (2009) · HORMONES · doi:10.14310/horm.2002.1233 · Cited by 79
Autonomous cortisol secretion in adrenal incidentalomas
Castro, M. A., Núñez, M. A. S., & Marazuela, M. (2019) · Endocrine · doi:10.1007/s12020-019-01888-y · Cited by 76
Eller-Vainicher, C., Morelli, V., Salcuni, A. S., Torlontano, M., Coletti, F., Iorio, L., Cuttitta, A., Ambrosio, A., Vicentini, L., Carnevale, V., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0775 · Cited by 75
Aron, D. C., Terzolo, M., & Cawood, T. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.06.012 · Cited by 74
Mechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review
Chiodini, I., Vainicher, C. E., Morelli, V, Palmieri, S., Cairoli, E., Salcuni, A. S., Copetti, M., & Scillitani, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0289 · Cited by 73
Eller-Vainicher, C., Morelli, V., Salcuni, A. S., Battista, C., Torlontano, M., Coletti, F., Iorio, L., Cairoli, E., Beck-Peccoz, P., Arosio, M., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0602 · Cited by 73
Systematic review of surgical treatment of subclinical Cushing's syndrome
Iacobone, M., Citton, M., Scarpa, M., Viel, G., Boscaro, M., & Nitti, D. (2015) · British journal of surgery · doi:10.1002/bjs.9742 · Cited by 74
Adrenal incidentaloma: evaluation and management
Singh, P. K., & Buch, H. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.044313 · Cited by 70
Subclinical Cushing's syndrome
Terzolo, M., Bovio, S., Pia, A. R., Osella, G., Borretta, G., Angeli, A., & Reimondo, G. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800013 · Cited by 67
Glucose metabolism in patients with subclinical Cushing’s syndrome
Giordano, R., Guaraldi, F., Berardelli, R., Karamouzis, I., D’Angelo, V., Marinazzo, E., Picu, A., Ghigo, E., & Arvat, E. (2012) · Endocrine · doi:10.1007/s12020-012-9628-9 · Cited by 64
Subclinical Cushing’s syndrome
Leo, M. D., Cozzolino, A., Colao, A. A. L., & Pivonello, R. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.02.001 · Cited by 65
Vassiliadi, D. A., Ntali, G., Vicha, E., & Tsagarakis, S. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03963.x · Cited by 61
The clinical significance of adrenal incidentalomas
Androulakis, I. I., Kaltsas, G., Piaditis, G. P., & Grossman, A. B. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02436.x · Cited by 61
Debono, M., Chadarévian, R., Eastell, R., Ross, R. J. M., & Newell-Price, J. D. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060984 · Cited by 60
Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma
Ermetici, F., Malavazos, A. E., Corbetta, S., Morricone, L. F., Dall’Asta, C., Romanelli, M. M. C., & Ambrosi, B. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.018 · Cited by 59
Muscogiuri, G., Sorice, G. P., Prioletta, A., Mezza, T., Cipolla, C., Salomone, E., Giaccari, A., Pontecorvi, A., & Della Casa, S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03928.x · Cited by 52
Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.
Mazzuco, T. L., Bourdeau, I., & Lacroix, A. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32832b7043 · Cited by 48
Adrenal Incidentaloma—A Modern Disease with Old Complications
Angeli, A., & Terzolo, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021436 · Cited by 47
Tsatsoulis, A. A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7030037 · Cited by 48
Peppa, Μ., Koliaki, C. C., & Raptis, S. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02291.x · Cited by 44
Akehi, Y., Kawate, H., Murase, K., Nagaishi, R., Nomiyama, T., Nomura, M., Takayanagi, R., & Yanase, T. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej12-0458 · Cited by 42
Adrenocortical tumors and insulin resistance: What is the first step?
Altieri, B., Tirabassi, G., Casa, S. D., Ronchi, C. L., Balercia, G., Orio, F., Pontecorvi, A., Colao, A., & Muscogiuri, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.29950 · Cited by 39
Cardiovascular Risk in Patients with Nonfunctional Adrenal Incidentaloma: Myth or Reality?
Erbil, Y., Özbey, N., Barbaros, U., Ünalp, H. R., Salmaslıoğlu, A., & Özarmağan, S. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0178-0 · Cited by 37
Endocrine incidentalomas—challenges imposed by incidentally discovered lesions
Vassiliadi, D. A., & Tsagarakis, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.92 · Cited by 37
Cava, G. L., Impériale, A., Olianti, C., Gheri, G., Ladu, C., Mannelli, M., & Pupi, A. (2003) · PubMed · Cited by 36
Echocardiographic alterations in patients with non-functioning adrenal incidentaloma
Ermetici, F., Dall’Asta, C., Malavazos, A. E., Coman, C., Morricone, L. F., Montericcio, V., & Ambrosi, B. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346410 · Cited by 36
Subclinical Cushing’s syndrome: Current concepts and trends
Zografos, G. N., Perysinakis, I., & Vassilatou, E. (2014) · HORMONES · doi:10.14310/horm.2002.1506 · Cited by 33
The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis
Malaguarnera, R., Morcavallo, A., & Belfiore, A. (2012) · Journal of Oncology · doi:10.1155/2012/635614 · Cited by 33
Pathophysiology, Evaluation, and Medical Management of Adrenal Disorders
Kutikov, A., Crispen, P. L., & Uzzo, R. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00057-8 · Cited by 31
Ogura, M., Kusaka, I., Nagasaka, S., Yatagai, T., Shinozaki, S., Itabashi, N., Nakamura, T., Yokoyama, M., Ishikawa, S., & Ishibashi, S. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.715 · Cited by 31
Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes
Dalmazi, G. D., & Pasquali, R. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000153 · Cited by 31
Castro, M. A., Ojeda, C. M., Ramírez, M. N. S., Santos, V. G. D., Corrales, E. P., & Fernández-Argüeso, M. (2022) · Endocrine · doi:10.1007/s12020-022-03120-w · Cited by 30
Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity
Castro, M. A., Corrales, E. P., & Lamas, C. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.01.005 · Cited by 36
Yener, S., Ertilav, S., Seçil, M., Akıncı, B., Demir, T., Kebapçılar, L., & Yeşil, Ş. (2012) · Medical Principles and Practice · doi:10.1159/000336589 · Cited by 30
Podbregar, A., Janež, A., Goričar, K., & Jensterle, M. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00599-0 · Cited by 25
Emral, R., Aydoğan, B. İ., Köse, A. D., Demir, Ö., & Çorapçıoğlu, D. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.01.007 · Cited by 24
Insulin resistance and adrenal incidentalomas: A bidirectional relationship
Sydney, G. I., Ioakim, K. J., & Paschou, S. Α. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.12.002 · Cited by 23
Adrenal incidentaloma imaging – the first steps in therapeutic management
Ćwikła, J. B. (2013) · Polish Journal of Radiology · doi:10.12659/pjr.889541 · Cited by 21
Starker, L. F., Kunstman, J. W., & Carling, T. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.02.008 · Cited by 21
Castro, M. A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14745 · Cited by 20
Adrenal Incidentaloma (Adrenaloma)
Linos, D. A. (2003) · HORMONES · doi:10.14310/horm.2002.1178 · Cited by 20
Khan, U. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_52_19 · Cited by 20
New Approaches to the Minimally Invasive Treatment of Adrenal Lesions
Ogilvie, J. B., & Duh, Q. (2005) · The Cancer Journal · doi:10.1097/00130404-200501000-00010 · Cited by 20
Izaki, H., Fukumori, T., Takahashi, M., Taue, R., Kishimoto, T., Tanimoto, S., Nishitani, M., & Kanayama, H. (2006) · International Journal of Urology · doi:10.1111/j.1442-2042.2006.01384.x · Cited by 19
Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels
Yener, S., Comlekci, A., Akıncı, B., Seçil, M., Demir, T., Ertilav, S., & Yeşil, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345724 · Cited by 17
Adipokine and cytokine levels in non-functioning adrenal incidentalomas (NFAI)
Babińska, A., Kaszubowski, M. F., & Sworczak, K. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0066 · Cited by 16
Traditional and novel cardiovascular risk factors in non-functioning adrenal adenomas
Yener, S., Çömlekçi, A., Yüksel, F., Sevınç, A. I., Ertilav, S., & Yeşil, S. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.08.009 · Cited by 15
From Type-1 Diabetes HPA Axis to the Disease Complications
Prevatto, R. C. T. J. P., & Martinsand, P. M. S. M. A. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s12-002 · Cited by 15
Hormonal and metabolic evaluation of adrenal incidentalomas
Wagnerová, H., Dudasova, D., & Lazúrová, I. (2009) · Neoplasma · doi:10.4149/neo_2009_06_521 · Cited by 14
Xu, T., Xia, L., Wang, X., Zhang, X., Zhong, S., Qin, L., Zhang, X., Zhu, Y., & Shen, Z. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0841-8 · Cited by 14
Abe, I., Sugimoto, K., Miyajima, T., Ide, T., Minezaki, M., Takeshita, K., Takahara, S., Nakagawa, M., Fujimura, Y., Kudo, T., et al. (2018) · Internal Medicine · doi:10.2169/internalmedicine.0550-17 · Cited by 12
Prevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus
Hiroi, N., Sue, M., Yoshihara, A., Ichijo, T., Yoshida-Hiroi, M., Higa, M., & Yoshino, G. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-71 · Cited by 12
Mauclère-Denost, S., Duron-Martinaud, S., Nunes, M. L., Gatta‐Cherifi, B., Fagour, C., Rault, A., Gosse, P., & Tabarin, A. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.03.005 · Cited by 11
Tsentidis, C., Bampilis, A., Ntova, V., Fragkos, D., Panos, C., Limniati, C., & Kassi, G. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0754-6464 · Cited by 10
Harman, E., Karadeniz, M., Biray, C., Zengi, A., Çetinkalp, Ş., Özgen, G., Saygılı, F., Berdeli, A., Gündüz, C., & Yılmaz, C. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345766 · Cited by 11
Han, M., Cao, X., Zhao, C., Yang, L., Yin, N., Shen, P., Zhang, J., Gao, F., Ren, Y., Liang, D., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.544752 · Cited by 10
Gontarz-Nowak, K., Szklarz, M., Szychlińska, M., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2023) · Medicina · doi:10.3390/medicina59071234 · Cited by 10
Lazúrová, I., Spišáková, D., Wagnerová, H., Habalová, V., Dravecká, I., Petrášová, D., Drahovská, I., & Pundová, L. (2011) · Wiener klinische Wochenschrift · doi:10.1007/s00508-011-0064-2 · Cited by 10
Villéon, B. D. L., Bonnet, S., Gouya, H., Groussin, L., Tenenbaum, F., Gaujoux, S., & Dousset, B. E. (2016) · Surgery · doi:10.1016/j.surg.2016.03.008 · Cited by 9
Incidentalomas suprarrenales: experiencia clínica en los hospitales de Castilla-La Mancha
Lamas, C., Palma, M., Martín, D., de Frutos, V. Á., López, M., & Marco, A. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)72708-1 · Cited by 8
Krzyżewska, K., Niemczuk, E., Myśliwiec, B. J., & Junik, R. (2017) · Endokrynologia Polska · doi:10.5603/ep.a2017.0034 · Cited by 8
Adrenal incidentalomas and subclinical Cushing’s syndrome
Abdelmannan, D. K., & Aron, D. C. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9141-5 · Cited by 8
Indications and Results of Surgery for Incidentally Found Adrenal Tumors
Meyer, A. A., & Behrend, M. (2006) · Urologia Internationalis · doi:10.1159/000093915 · Cited by 8
Update on the Diagnosis of Cushing Syndrome
Liu, H., & Crapo, L. M. (2005) · The Endocrinologist · doi:10.1097/01.ten.0000162374.56442.ea · Cited by 8
Karaköse, M., Karbek, B., Şahi̇n, M., Arslan, M. S., Topaloğlu, O., Erden, G., Demirci, T., Çalışkan, M., & Delibaşı, T. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000008 · Cited by 7
Tabarin, A., Bardet, S., Bertherat, J. Y., Chabre, O., Dupas, B., Hamoir, E., Laurent, F., Tenenbaum, F., Cazalda, M., Rohmer, V., et al. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.09.002 · Cited by 7
Wang, Q., Lv, D., Wen, J., Zhou, H., Jia, M., Li, J., Du, H., & Shuang, W. (2025) · BMC Cancer · doi:10.1186/s12885-025-13774-0 · Cited by 6
Nishikawa, T., Saito, J., & Omura, M. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00207-x · Cited by 6
Etiologies of Cushing’s Syndrome
Newell-Price, J. D. C. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_2 · Cited by 6
Insulin sensitivity in patients with adrenal incidentaloma
Ivović, M., Vujović, S., Penezić, Z., Žarković, M., & Drezgić, M. (2006) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0608315i · Cited by 6
Prevalence and Incidence of Dementia in Patients With Non‐Overtly Functional Adrenal Tumours
Mirzaei, H., Patrova, J., Mannheimer, B., Lindh, J. D., & Falhammar, H. (2024) · Clinical Endocrinology · doi:10.1111/cen.15186 · Cited by 5
Bleier, J., Shlomai, G., Fishman, B., Dotan, Z., Rosenzweig, B., & Tirosh, A. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0111 · Cited by 5
Yilmaz, M. O., & Keles, F. O. (2021) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2021_080 · Cited by 5
Metabolic and cardiovascular impact of non-functioning adrenal adenomas: A clinical dilemma
Yener, S. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.02.005 · Cited by 5
Metadata
- Authors
- Midorikawa, S., Sanada, H., Hashimoto, S., Suzuki, T., & Watanabe, T.
- Affiliations
- Fukushima Medical University (JP)
- Corresponding author
- Midorikawa, Sanae
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2001-06
- Volume
- 54
- Issue
- 6
- Pages
- 797-804
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2039932949
- Cited by
- 134
- References
- 26
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 7 · 2018: 7 · 2017: 1 · 2016: 5 · 2015: 7 · 2014: 6 · 2013: 7 · 2012: 10
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- insulin resistance, adrenal incidentaloma, adrenalectomy, adrenal adenoma, glucose tolerance, hypertension, insulin sensitivity, steady-state plasma glucose, myelolipoma, endothelioma, adrenal myelolipoma
- MeSH terms
- Adenoma, Adrenal Cortex Neoplasms, Adrenalectomy, Adult, Aged, Blood Glucose, Child, Preschool, Cushing Syndrome, Female, Glucose Tolerance Test, Humans, Hypertension, Insulin Resistance, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
